Spotlight
Clinical
Events
CME
Partners
Subscribe
- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
Corneal surface can be rebuilt with patient’s oral mucosal epithelium
Osaka, Japan-Sheets of tissue-engineered epithelial cells from a patient's oral mucosal epithelium can be used as a source of cells to rebuild a destroyed corneal surface. This unique approach is an alternative to allograft transplantation and it eliminates the need for immunosuppressive therapy.
Related Videos
Related Content
